Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Lazertinib
Locations
1
South Korea
Samsung Medical Center
Seoul, South Korea
Start Date
July 31, 2022
Primary Completion Date
June 30, 2024
Completion Date
June 30, 2024
Last Updated
May 19, 2022
NCT06349642
NCT04751747
NCT04151940
NCT04780568
NCT06249282
NCT06573073
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions